Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Lipase H is important for hair follicle function and shaping hair fibers.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The combination treatment showed a higher response rate but no significant survival benefits.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

MVP treatment is effective and safe for recurrent breast cancer.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Targeting colon cancer stem cells might lead to better treatment results.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Some breast cancer chemotherapy can cause permanent hair loss.

Finasteride may help treat chronic CSC, improving vision.

Some medications can cause acne, and stopping these drugs is the main treatment.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.